Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Carme Camps

Post-doctoral researcher

Work summary

I am a molecular and computational biologist with an interest in genomics and personalised medicine. My current research within the Oxford BRC focuses on the identification of genetic defects that lead to rare diseases, especially in disorders within the immunological, haematological and hepatic domains. I do this through the analysis and interpretation of Whole Genome Sequencing (WGS) generated for hundreds of cases recruited through the HICF2 programme, and other omics data when available. For certain findings, I conduct experimental validation of the predicted mechanism of action. I am also involved in the analysis of data from the 100K genomes project (Genomics England) as part of the Immune GeCIP.

I am particularly interested in the investigation of digenic inheritance and in the identification of disease-causing variants in the non-coding region. A recent example, done in collaboration with Holger Cario and Betty Gardie, includes the discovery of a new cryptic exon hidden in the first intron of the VHL gene. Variants found within this region in patients with erythrocytosis or von Hippel-Lindau disease induced a dysregulation of the VHL splicing with excessive retention of the cryptic exon associated with a downregulation of VHL protein expression.

Initial work within the Oxford BRC involved the development and use of two gene panels that led successfully to the identification of disease-causing variants in erythrocitosis patients and prognostic biomarkers in colorectal cancer. Previously, I worked with Dr. Jiannis Ragoussis in the study of microRNA expression regulation and the detection of microRNAs as independent prognostic factors in breast cancer.

Key publications

Recent publications

More publications